View source for 20240043938. BIOMARKER PANEL AND METHODS FOR DETECTING MICROSATELLITE INSTABILITY IN CANCERS simplified abstract (Biocartis NV)

=BIOMARKER PANEL AND METHODS FOR DETECTING MICROSATELLITE INSTABILITY IN CANCERS=


==Organization Name==

[[:Category:Biocartis NV|Biocartis NV]]


[[Category:Biocartis NV]]

==Inventor(s)==

[[:Category:Bram De Craene of Mechelen (BE)|Bram De Craene of Mechelen (BE)]][[Category:Bram De Craene of Mechelen (BE)]]

[[:Category:Klaas Decanniere of Mechelen (BE)|Klaas Decanniere of Mechelen (BE)]][[Category:Klaas Decanniere of Mechelen (BE)]]

[[:Category:Jan Van De Velde of Mechelen (BE)|Jan Van De Velde of Mechelen (BE)]][[Category:Jan Van De Velde of Mechelen (BE)]]

[[:Category:Geert Maertens of Mechelen (BE)|Geert Maertens of Mechelen (BE)]][[Category:Geert Maertens of Mechelen (BE)]]

==BIOMARKER PANEL AND METHODS FOR DETECTING MICROSATELLITE INSTABILITY IN CANCERS - A simplified explanation of the abstract==


This abstract first appeared for US patent application 20240043938 titled 'BIOMARKER PANEL AND METHODS FOR DETECTING MICROSATELLITE INSTABILITY IN CANCERS

==Simplified Explanation==

The present invention is related to the field of cancer, specifically cancers with microsatellite instability (MSI) and/or mismatch repair (MMR-) deficiency. Examples of such cancers include colorectal, gastric, and endometrial tumors. The invention provides a novel diagnostic marker panel for analyzing MSI loci, along with methods and kits for using this panel to detect cancers with MSI and/or MMR- deficiency.

* The invention is a diagnostic marker panel for analyzing MSI loci.
* The panel can be used to detect cancers with MSI and/or MMR- deficiency.
* The invention includes methods and kits for using the panel in cancer detection.

Potential applications of this technology:

* Improved diagnosis and detection of cancers with MSI and/or MMR- deficiency.
* Personalized treatment strategies for patients with these types of cancers.
* Monitoring the effectiveness of cancer treatments targeting MSI and/or MMR- deficiency.

Problems solved by this technology:

* Current methods for detecting cancers with MSI and/or MMR- deficiency may be complex and time-consuming.
* The invention provides a simplified and efficient approach for analyzing MSI loci and detecting these types of cancers.

Benefits of this technology:

* Early and accurate detection of cancers with MSI and/or MMR- deficiency.
* Facilitates personalized treatment plans for patients.
* Potential for improved patient outcomes and survival rates.


==Original Abstract Submitted==

the present invention generally relates to the field of cancer, in particular to cancers having microsatellite instability (msi) and/or mismatch repair (mmr-) deficiency. examples of such cancers include many colorectal, gastric, and endometrial tumors. accordingly, the present invention provides a novel diagnostic marker panel for analyzing msi loci, together with methods and kits of using said panel in the detection of cancers having microsatellite instability (msi) and/or mismatch repair (mmr-) deficiency.



[[Category:C12Q1/6886]]